143 related articles for article (PubMed ID: 28532114)
1. Hypocrellin B and nano silver loaded polymeric nanoparticles: Enhanced generation of singlet oxygen for improved photodynamic therapy.
Natesan S; Krishnaswami V; Ponnusamy C; Madiyalakan M; Woo T; Palanisamy R
Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():935-946. PubMed ID: 28532114
[TBL] [Abstract][Full Text] [Related]
2. Development of copolymeric nanoparticles of hypocrellin B: Enhanced phototoxic effect and ocular distribution.
Krishnaswami V; Ponnusamy C; Sankareswaran S; Paulsamy M; Madiyalakan R; Palanichamy R; Kandasamy R; Natesan S
Eur J Pharm Sci; 2018 Apr; 116():26-36. PubMed ID: 29055734
[TBL] [Abstract][Full Text] [Related]
3. Hypocrellin B and paclitaxel-encapsulated hyaluronic acid-ceramide nanoparticles for targeted photodynamic therapy in lung cancer.
Chang JE; Cho HJ; Yi E; Kim DD; Jheon S
J Photochem Photobiol B; 2016 May; 158():113-21. PubMed ID: 26967521
[TBL] [Abstract][Full Text] [Related]
4. Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model.
Babu A; Jeyasubramanian K; Gunasekaran P; Murugesan R
J Biomed Nanotechnol; 2012 Feb; 8(1):43-56. PubMed ID: 22515093
[TBL] [Abstract][Full Text] [Related]
5. Photocytotoxicity of hypocrellin B (HB) was enhanced by liposomalization in vitro.
Zhou Z; Zhang L; Liu H; Zhang Q; Liu B; Ai P; Ma H; Liu W; Li Z; Sheng W; Zeng Y; Zhong R
Int J Toxicol; 2011 Mar; 30(2):174-80. PubMed ID: 21536921
[TBL] [Abstract][Full Text] [Related]
6. EPR and spectrophotometric studies on free radicals (O2.-, Cysa-HB.-) and singlet oxygen (1O2) generated by irradiation of cysteamine substituted hypocrellin B.
He YY; An JY; Jiang LJ
Int J Radiat Biol; 1998 Nov; 74(5):647-54. PubMed ID: 9848284
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable Hypocrellin B nanoparticles coated with neutrophil membranes for hepatocellular carcinoma photodynamics therapy effectively via JUNB/ROS signaling.
Zhang Z; Li D; Cao Y; Wang Y; Wang F; Zhang F; Zheng S
Int Immunopharmacol; 2021 Oct; 99():107624. PubMed ID: 34343939
[TBL] [Abstract][Full Text] [Related]
8. Cytoprotective role of nitric oxide in HepG2 cell apoptosis induced by hypocrellin B photodynamic treatment.
Ji YY; Ma YJ; Wang JW
J Photochem Photobiol B; 2016 Oct; 163():366-73. PubMed ID: 27619738
[TBL] [Abstract][Full Text] [Related]
9. Photobleaching of hypocrellin B and its butylamino-substituted derivative in solutions.
Xu S; Tian C; Chen S; Zhang M; Shen T
Photochem Photobiol; 2001 Aug; 74(2):184-90. PubMed ID: 11547552
[TBL] [Abstract][Full Text] [Related]
10. Cyclohexylamino-demethoxy-hypocrellin B and photodynamic therapy decreases human cancer in vitro.
Xu S; Chen S; Zhang M; Shen T; Liu Z; Zhao Y; Wu Y
Anticancer Drug Des; 2001 Dec; 16(6):271-7. PubMed ID: 12375880
[TBL] [Abstract][Full Text] [Related]
11. A nanoencapsulated hypocrellin A prepared by an improved microemulsion method for photodynamic treatment.
Zhou L; Ning YW; Wei SH; Feng YY; Zhou JH; Yu BY; Shen J
J Mater Sci Mater Med; 2010 Jul; 21(7):2095-101. PubMed ID: 20364361
[TBL] [Abstract][Full Text] [Related]
12. Preclinical assessment of hypocrellin B and hypocrellin B derivatives as sensitizers for photodynamic therapy of cancer: progress update.
Miller GG; Brown K; Ballangrud AM; Barajas O; Xiao Z; Tulip J; Lown JW; Leithoff JM; Allalunis-Turner MJ; Mehta RD; Moore RB
Photochem Photobiol; 1997 Apr; 65(4):714-22. PubMed ID: 9114749
[TBL] [Abstract][Full Text] [Related]
13. Investigation of photobleaching of hypocrellin B in non-polar organic solvent and in liposome suspension.
Yu C; Xu S; Chen S; Zhang M; Shen T
J Photochem Photobiol B; 2002 Nov; 68(2-3):73-8. PubMed ID: 12468200
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
15. Poly(D, L-lactide-co-glycolide) nanoparticles as delivery agents for photodynamic therapy: enhancing singlet oxygen release and photototoxicity by surface PEG coating.
Boix-Garriga E; Acedo P; Casadó A; Villanueva A; Stockert JC; Cañete M; Mora M; Sagristá ML; Nonell S
Nanotechnology; 2015 Sep; 26(36):365104. PubMed ID: 26293792
[TBL] [Abstract][Full Text] [Related]
16. Photogeneration of singlet oxygen (1O2) and free radicals (Sen*-, O2*-) by tetra-brominated hypocrellin B derivative.
Ma J; Jiang L
Free Radic Res; 2001 Dec; 35(6):767-77. PubMed ID: 11811528
[TBL] [Abstract][Full Text] [Related]
17. Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles.
Chang JE; Cho HJ; Jheon S
J Vis Exp; 2016 Dec; (118):. PubMed ID: 27929475
[TBL] [Abstract][Full Text] [Related]
18. Effect of structural modification on photodynamic activity of hypocrellins.
Ma J; Zhao J; Jiang L
Photochem Photobiol; 2001 Aug; 74(2):143-8. PubMed ID: 11547547
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic properties of a bispyrrolecarboxamide-modified hypocrellin B: the role of affinity and ascorbic acid.
Liu Y; Zhou Q; Zeng Z; Qiao R; Wang X; Zhang B
J Phys Chem B; 2008 Aug; 112(32):9959-65. PubMed ID: 18646820
[TBL] [Abstract][Full Text] [Related]
20. Enhanced effect of photodynamic therapy in ovarian cancer using a nanoparticle drug delivery system.
Li Z; Sun L; Lu Z; Su X; Yang Q; Qu X; Li L; Song K; Kong B
Int J Oncol; 2015 Sep; 47(3):1070-6. PubMed ID: 26165140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
